BTIG Maintains Buy on Insulet, Raises Price Target to $260
Portfolio Pulse from Benzinga Newsdesk
BTIG analyst Marie Thibault maintains a Buy rating on Insulet (NASDAQ:PODD) and raises the price target from $250 to $260.
October 14, 2024 | 4:54 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
BTIG analyst Marie Thibault has reaffirmed a Buy rating on Insulet and increased the price target from $250 to $260, indicating confidence in the company's future performance.
The reaffirmation of a Buy rating and an increase in the price target by a reputable analyst suggests a positive outlook for Insulet. This is likely to boost investor confidence and could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100